Biologics Industry to Grow at 8.8% CAGR as Biotech Innovation Accelerates
The global biologics industry was valued at US$ 448.8 billion in 2024 and is expected to reach US$ 1,140.2 billion by the end of 2035, expanding at a CAGR of 8.8% from 2025 to 2035. The market growth is driven by the increasing demand for targeted therapies, rising prevalence of chronic diseases, and continuous advancements in biotechnology and biopharmaceutical research. Additionally, growing...
0 Yorumlar 0 hisse senetleri 64 Views 0 önizleme